Aprea Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Aprea Therapeutics Inc
TickerAPRE
CIK #0001781983
CUSIP03836J201
SectorLife Sciences - Pharmaceutical Preparations
Address535 Boylston Street, Boston, MA 02116
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Aprea Therapeutics Inc 2025-12-29 3.1 M Exemption: 506(b) · Remaining: $2,727,944 · Duration: One year or less · Commission: $209,999 · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001781983] 10-K
[0001781983] 10-Q
[0001781983] 3
[0001781983] 4
[0001781983] 8-K
[0001781983] D
[0001781983] SC 13D
[0001781983] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vestal Point Capital LP Aprea Therapeutics Inc [2026-05-15] 0.0
Squadron Capital Management LLC Aprea Therapeutics Inc [2026-04-07] 0.0
Soleus Private Equity Fund III LP Aprea Therapeutics Inc [2026-04-01] 0.0
Lytton Laurence W Aprea Therapeutics Inc [2025-11-17] 0.0
Nantahala Capital Management LLC Aprea Therapeutics Inc [2024-11-14] 0.0
Stonepine Capital Management LLC Aprea Therapeutics Inc [2024-10-10] 6.6
SIO Capital Management LLC Aprea Therapeutics Inc [2024-02-14] 7.49
Hirschman Orin Aprea Therapeutics Inc [2023-03-03] 9.2
Morgan Stanley Aprea Therapeutics Inc [2021-03-24] 5.1
KDEV Investments AB Aprea Therapeutics Inc [2020-02-14] 11.6
Janus Henderson Group PLC Aprea Therapeutics Inc [2020-02-14] 8.6
Sectoral Asset Management Inc Aprea Therapeutics Inc [2020-02-13] 7.0
FMR LLC Aprea Therapeutics Inc [2019-11-12] 0.0
Versant Ventures V LLC Aprea Therapeutics Inc [2019-10-17] 12.1
5AM Ventures IV LP Aprea Therapeutics Inc [2019-10-17] 11.0
HealthCap VII LP Aprea Therapeutics Inc [2019-10-17] 11.9
Rock Springs Capital Management LP Aprea Therapeutics Inc [2019-10-11] 4.46
Redmile Group LLC Aprea Therapeutics Inc [2019-10-09] 10.9
Form 3/4/5 Filer 2011 - 2026
Henneman John B III
Aprea Therapeutics Inc
Pamukcu Rifat
Duey Marc
Grissinger Michael
Gruia Gabriela
Peters Richard
Bizzari Jean-Pierre
Seizinger Bernd R
Hamill John P
Gilad Oren
Mirza Nadeem Q
Korbel Gregory Alan
Schade Christian S
Coiante Scott M
Attar Eyal C
Abrahmsen Lars B
Namouni Fouad
Kelly Michael Aaron
Wessels Gregory S
Redmile Group LLC
Green Jeremy
5AM Opportunities I GP LLC
5AM Ventures IV LP
5AM Opportunities I LP
5AM Partners IV LLC
5AM Co-Investors IV LP
Schwab Andrew J
Parmar Kush
Diekman John D
Rocklage Scott M
Karolinska Development AB
KDev Investments AB
KCIF Co-Investment Fund KB
Christenson Johan
Hepple Jonathan
Versant Ventures V LLC
Versant Venture Capital V LP
Versant Affiliates Fund V LP
Versant Ventures V Canada LP
Versant Venture Capital V Canada LP
Versant Ophthalmic Affiliates I LP
Versant V Luxco Sa rl
Versant Vantage I LP
Versant Vantage I GP LP
Versant Vantage I GP-GP LLC
HealthCap VII LP
HealthCap VII GP SA
Magni Guido
Versant Ventures V GP-GP Canada Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hamill John P
Stock Options (Right to Buy) · derivative
2026-03-12 Grant 40,380 $0.00
Gilad Oren
Stock Options (Right to Buy) · derivative
2026-03-12 Grant 80,700 $0.00
Hamill John P
Common Stock
2026-03-12 Grant 10,095 $0.00
Gilad Oren
Common Stock
2026-03-12 Grant 20,175 $0.00
Hamill John P
Common Warrant · derivative
2026-01-30 Buy 5,700
Gilad Oren
Common Warrant · derivative
2026-01-30 Buy 28,100
Gilad Oren
Common Stock
2026-01-30 Buy 28,100 $0.89 25,009
Hamill John P
Common Stock
2026-01-30 Buy 5,700 $0.89 5,073
Gilad Oren
Pre-Funded Warrant · derivative
2025-12-10 Buy 21,459 $1.17 25,107
Duey Marc
Common Stock
2025-12-10 Buy 21,459 $1.17 25,107
Hamill John P
Common Stock
2025-12-10 Buy 5,000 $1.17 5,850
Duey Marc
Common Warrant · derivative
2025-12-10 Buy 21,459
Hamill John P
Common Warrant · derivative
2025-12-10 Buy 5,000
Gilad Oren
Common Warrants · derivative
2025-12-10 Buy 21,459
Bizzari Jean-Pierre
Stock Options (Right to Buy) · derivative
2025-06-05 Grant 4,185 $0.00
Seizinger Bernd R
Common Stock
2025-06-05 Grant 1,045 $0.00
Peters Richard
Common Stock
2025-06-05 Grant 1,045 $0.00
Pamukcu Rifat
Common Stock
2025-06-05 Grant 1,045 $0.00
Henneman John B III
Common Stock
2025-06-05 Grant 1,045 $0.00
Gruia Gabriela
Common Stock
2025-06-05 Grant 1,045 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 22 2,244,310
2025-12-31 22 1,695,512
2025-09-30 23 1,618,851
2025-06-30 24 1,815,208
2025-03-31 27 1,949,704
2024-12-31 27 2,077,381
2024-09-30 23 2,138,273
2024-06-30 29 2,289,874
2024-03-31 25 1,679,029
2023-12-31 22 1,048,403
2023-09-30 23 981,652
2023-06-30 21 986,076
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com